Top Markets
Coin of the day
Winsan (Chengdu) Medical Science and Technology Co., Ltd. Winsan (Chengdu) Medical Science and Technology Co., Ltd.

Winsan (Chengdu) Medical Science and Technology Co., Ltd.

600767
주식 순위 #29539
Winsan (Chengdu) Medical Science and Technology Co., Ltd. is a Chinese... Winsan (Chengdu) Medical Science and Technology Co., Ltd. is a Chinese enterprise dedicated to a broad spectrum of healthcare services and solutions. Its operations encompass medical digitalization, remote healthcare, online health management platforms, and the provision of medical equipment and direct patient care. The company develops extensive health information systems, offering tools for regional population health insights, traditional Chinese medicine integration, and optimizing hospital performance. These systems also support home-based elder care, chronic disease management, telemedicine consultations, medical insurance processing, and pharmacy services. Furthermore, Winsan operates the Jingde County Chinese Medicine Hospital, a non-profit, second-class facility specializing in traditional Chinese medicine. They also supply medical institutions with crucial items like testing reagents, instruments, and consumables, alongside delivering clinical diagnostic services. Founded in 1993, the company adopted its current name in April 2020, having previously been known as Winsan (Shanghai) Medical Science and Technology Co., Ltd., and maintains its headquarters in Shanghai, China.
주가
$0.06086383
마지막 동기화: 2023-06-20
시가총액
$20.76M
변동 (1일)
1.37%
변동 (1년)
0.00%
국가
CN
거래 Winsan (Chengdu) Medical Science and Technology Co., Ltd. (600767)

카테고리

Winsan (Chengdu) Medical Science and Technology Co., Ltd. (600767)의 수익
2026 기준 수익 TTM: 0
Winsan (Chengdu) Medical Science and Technology Co., Ltd.의 최신 재무 보고서에 따르면 회사의 현재 수익은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 수익 0과 동일입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Winsan (Chengdu) Medical Science and Technology Co., Ltd.의 수익 기록 (2026 ~ 2026)
연말 수익
연도 수익 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 수익